These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 24094713)
21. Malignant head/neck paragangliomas. Comparative study. Mediouni A; Ammari S; Wassef M; Gimenez-Roqueplo AP; Laredo JD; Duet M; Tran Ba Huy P; Oker N Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Jun; 131(3):159-66. PubMed ID: 24239180 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical Expression of Choline Acetyltransferase and Catecholamine-Synthesizing Enzymes in Head-and-Neck and Thoracoabdominal Paragangliomas and Pheochromocytomas. Kimura N; Shiga K; Kaneko KI; Oki Y; Sugisawa C; Saito J; Tawara S; Akahori H; Sogabe S; Yamashita T; Takekoshi K; Naruse M; Katabami T Endocr Pathol; 2021 Dec; 32(4):442-451. PubMed ID: 34743284 [TBL] [Abstract][Full Text] [Related]
23. Head and Neck Paraganglioma (HNPGL) Registry: A study protocol for prospective data collection in patients with Head and Neck Paragangliomas. de Bresser CJM; van Nesselrooij BPM; van Treijen MJC; Braat AJAT; de Ridder M; Stokroos RJ; de Bree R; de Borst GJ; Rijken JA; Petri BJ PLoS One; 2024; 19(7):e0307311. PubMed ID: 39052568 [TBL] [Abstract][Full Text] [Related]
24. Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol. Blanchet EM; Millo C; Martucci V; Maass-Moreno R; Bluemke DA; Pacak K Clin Nucl Med; 2014 Mar; 39(3):243-50. PubMed ID: 24152658 [TBL] [Abstract][Full Text] [Related]
25. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators. Gimenez-Roqueplo AP; Caumont-Prim A; Houzard C; Hignette C; Hernigou A; Halimi P; Niccoli P; Leboulleux S; Amar L; Borson-Chazot F; Cardot-Bauters C; Delemer B; Chabolle F; Coupier I; Libé R; Peitzsch M; Peyrard S; Tenenbaum F; Plouin PF; Chatellier G; Rohmer V J Clin Endocrinol Metab; 2013 Jan; 98(1):E162-73. PubMed ID: 23162105 [TBL] [Abstract][Full Text] [Related]
26. FDG PET-CT imaging in head and neck paragangliomas: A centre experience. Boughdad S; O'Connor A; Cook GJ; Pike L; Connor S; Obholzer R; Warbey V Clin Endocrinol (Oxf); 2021 Aug; 95(2):315-322. PubMed ID: 33598922 [TBL] [Abstract][Full Text] [Related]
27. PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma. Janssen I; Chen CC; Millo CM; Ling A; Taieb D; Lin FI; Adams KT; Wolf KI; Herscovitch P; Fojo AT; Buchmann I; Kebebew E; Pacak K Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1784-91. PubMed ID: 26996779 [TBL] [Abstract][Full Text] [Related]
28. The management of head-and-neck paragangliomas. Capatina C; Ntali G; Karavitaki N; Grossman AB Endocr Relat Cancer; 2013 Oct; 20(5):R291-305. PubMed ID: 23921204 [TBL] [Abstract][Full Text] [Related]
29. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Timmers HJ; Gimenez-Roqueplo AP; Mannelli M; Pacak K Endocr Relat Cancer; 2009 Jun; 16(2):391-400. PubMed ID: 19190077 [TBL] [Abstract][Full Text] [Related]
30. Genetic and clinical characteristics of head and neck paragangliomas in a Chinese population. Zheng X; Wei S; Yu Y; Xia T; Zhao J; Gao S; Li Y; Gao M Laryngoscope; 2012 Aug; 122(8):1761-6. PubMed ID: 22566157 [TBL] [Abstract][Full Text] [Related]
32. Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine. Richter S; Qiu B; Ghering M; Kunath C; Constantinescu G; Luths C; Pamporaki C; Bechmann N; Meuter L; Kwapiszewska A; Deutschbein T; Nölting S; Peitzsch M; Robledo M; Prejbisz A; Pacak K; Gudziol V; Timmers HJLM; Eisenhofer G Endocr Relat Cancer; 2022 Mar; 29(4):213-224. PubMed ID: 35171114 [TBL] [Abstract][Full Text] [Related]
33. Kan Y; Zhang S; Wang W; Liu J; Yang J; Wang Z Acta Radiol; 2018 Dec; 59(12):1466-1474. PubMed ID: 29566550 [TBL] [Abstract][Full Text] [Related]
34. Clinical value of somatostatin receptor imaging in patients with suspected head and neck paragangliomas. Schmidt M; Fischer E; Dietlein M; Michel O; Weber K; Moka D; Stennert E; Schicha H Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1571-80. PubMed ID: 12458390 [TBL] [Abstract][Full Text] [Related]
36. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma. Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216 [TBL] [Abstract][Full Text] [Related]
37. Pheochromocytoma and paraganglioma: current functional and future molecular imaging. Blanchet EM; Martucci V; Pacak K Front Oncol; 2011; 1():58. PubMed ID: 22655253 [TBL] [Abstract][Full Text] [Related]
38. British Skull Base Society Clinical Consensus Document on Management of Head and Neck Paragangliomas. Lloyd S; Obholzer R; Tysome J; Otolaryngol Head Neck Surg; 2020 Sep; 163(3):400-409. PubMed ID: 32340547 [TBL] [Abstract][Full Text] [Related]
39. Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery. Nockel P; El Lakis M; Gaitanidis A; Merkel R; Patel D; Nilubol N; Prodanov T; Pacak K; Kebebew E Ann Surg; 2019 Apr; 269(4):741-747. PubMed ID: 29334561 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the Sensitivity of Dodamani MH; Jaiswal SK; Sarathi V; Marfatia H; D'Cruz A; Malhotra G; Hira P; Patil VA; Lila AR; Shah NS; Bandgar TR World J Nucl Med; 2022 Sep; 21(3):184-191. PubMed ID: 36060084 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]